Physician profile
Jayati K Singh
NPI 1477654481
$2,061.03
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $172 · 2021: $653 · 2022: $184 · 2023: $211 · 2024: $43.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $465.82 | 2021-2023 | Vraylar |
| Lundbeck LLC | $285.05 | 2019-2023 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $193.09 | 2019-2023 | Rexulti |
| Alkermes, INC. | $171.37 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $159.81 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $136.33 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $76.42 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $62.02 | 2021 | |
| Shire North American Group INC | $58.08 | 2019 | |
| Neurocrine Biosciences, INC. | $57.93 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $43.72 | 2019-2020 | |
| Allergan, INC. | $42.98 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $42.81 | 2019 | |
| Avanir Pharmaceuticals, INC. | $42.03 | 2019 | |
| Corium, LLC | $39.80 | 2022-2024 | Azstarys |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $39.63 | 2021 | |
| Eisai INC. | $39.25 | 2021 | |
| Indivior INC. | $34.13 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $31.46 | 2023-2024 | Jornay Pm |
| Bausch Health US, LLC | $27.61 | 2019-2021 | |
| Owp Pharmaceuticals, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayati Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.